home / stock / atnfw / atnfw quote
Last: | $0.01 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0112 |
Close: | $0.01 |
High: | $0.0112 |
Low: | $0.0098 |
Volume: | 4,588 |
Last Trade Date Time: | 07/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.01 | $0.0112 | $0.01 | $0.0112 | $0.0098 | 4,588 | 07-29-2024 |
$0.01 | $0.0097 | $0.01 | $0.0101 | $0.0097 | 11,042 | 07-26-2024 |
$0.0099 | $0.0086 | $0.0099 | $0.009999 | $0.0086 | 22,532 | 07-25-2024 |
$0.0093 | $0.0088 | $0.0093 | $0.0101 | $0.0087 | 24,354 | 07-24-2024 |
$0.0096 | $0.0101 | $0.0096 | $0.0101 | $0.0083 | 67,001 | 07-23-2024 |
$0.0087 | $0.0103 | $0.0087 | $0.0111 | $0.0087 | 47,995 | 07-22-2024 |
$0.011 | $0.011 | $0.011 | $0.011 | $0.01 | 17,308 | 07-19-2024 |
$0.0109 | $0.0103 | $0.0109 | $0.011 | $0.009 | 80,270 | 07-18-2024 |
$0.011799 | $0.0071 | $0.011799 | $0.0118 | $0.0071 | 39,754 | 07-17-2024 |
$0.0102 | $0.0081 | $0.0102 | $0.0107 | $0.0081 | 83,175 | 07-16-2024 |
$0.009 | $0.0085 | $0.009 | $0.01 | $0.0079 | 245,712 | 07-15-2024 |
$0.0085 | $0.01 | $0.0085 | $0.011 | $0.0084 | 142,321 | 07-12-2024 |
$0.0082 | $0.01 | $0.0082 | $0.0115 | $0.0073 | 358,701 | 07-11-2024 |
$0.0112 | $0.0115 | $0.0112 | $0.0138 | $0.0071 | 1,114,050 | 07-10-2024 |
$0.0121 | $0.0113 | $0.0121 | $0.0222 | $0.0088 | 3,022,025 | 07-09-2024 |
$0.01 | $0.012 | $0.01 | $0.012 | $0.009 | 23,188 | 07-08-2024 |
$0.0087 | $0.0102 | $0.0087 | $0.0102 | $0.0085 | 39,729 | 07-05-2024 |
$0.0101 | $0.0127 | $0.0101 | $0.013 | $0.01 | 57,638 | 07-04-2024 |
$0.0101 | $0.0127 | $0.0101 | $0.013 | $0.01 | 57,638 | 07-03-2024 |
$0.0096 | $0.01 | $0.0096 | $0.01 | $0.0095 | 195,671 | 07-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
180 Life Sciences Corp Wt Pur 1/2 Com Exp 11/07/2025 Company Name:
ATNFW Stock Symbol:
NASDAQ Market:
180 Life Sciences Corp Wt Pur 1/2 Com Exp 11/07/2025 Website:
MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammator...
MENLO PARK, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammator...
MENLO PARK, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in i...